Tag: Eli Lilly

Pharmaceutical giant Eli Lilly is facing its worst stock market performance in 25 years, with shares plummeting 14% in a ...

Eli Lilly is poised to capitalize on explosive growth in India for its diabetes and weight-loss drug Mounjaro, with sales ...

Eli Lilly’s rise in the lucrative weight-loss drug market has reached new heights, overshadowing its Danish rival, which has seen ...

Eli Lilly faces a pivotal moment as conflicting policy developments from the U.S. administration create waves in the pharmaceutical sector. ...